SWM
VBIV

Spire Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Spire Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33
Closed -$2K – 2948
2021
Q4 		$2K Buy
+33
New +$2.78K ﹤0.01% 2826
2021
Q2 		– Sell
-33
Closed -$3K – 3033
2021
Q1 		$3K Buy
+33
New +$3.35K ﹤0.01% 2791

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Spire Wealth Management's VBIV Position: Q1 2022 in Review

Spire Wealth Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2022, closing a stake of 33 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in VBIV in Q1 2021 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

  • Spire Wealth Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2022 after selling out during the quarter.
  • Spire Wealth Management sold 33 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022, an estimated $2K.
  • Spire Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 2 quarters.
  • Spire Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $3K in Q1 2021.
  • 131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.